Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Intrahepatic Cholangiocarcinoma”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269158
What this trial is testing

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsAdvanced CancerImmunotherapy
Yonsei University 160
Large-scale testing (Phase 3)UnknownNCT01470443
What this trial is testing

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Samsung Medical Center 240
Not applicableNot Yet RecruitingNCT07208526
What this trial is testing

Trial of Surgical Decision-Making Guided by TDTP-RECIST

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Conversion TherapyTDTP-RECIST+1 more
Shanghai Zhongshan Hospital 270
Very early researchLooking for participantsNCT06583993
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05251662
What this trial is testing

Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Testing effectiveness (Phase 2)UnknownNCT04211168
What this trial is testing

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer
Peking Union Medical College Hospital 44
Testing effectiveness (Phase 2)Looking for participantsNCT06728410
What this trial is testing

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Who this might be right for
Intrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation
Mehmet Akce 38
Testing effectiveness (Phase 2)Looking for participantsNCT05738057
What this trial is testing

Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Hua Li 22
Testing effectiveness (Phase 2)Study completedNCT03251443
What this trial is testing

Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaSecond-line Treatment
Peking Union Medical College Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT05422690
What this trial is testing

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma
Inova Health Care Services 16
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Testing effectiveness (Phase 2)Looking for participantsNCT06859684
What this trial is testing

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
West China Hospital 25
Large-scale testing (Phase 3)Looking for participantsNCT04353375
What this trial is testing

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Advanced Intrahepatic CholangiocarcinomaSolid Tumor, Adult
Hutchmed 235
Testing effectiveness (Phase 2)UnknownNCT01039181
What this trial is testing

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
National Science and Technology Development Agency, Thailand 28
Testing effectiveness (Phase 2)Looking for participantsNCT07169734
What this trial is testing

Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Who this might be right for
Cervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more
Alentis Therapeutics AG 180
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Testing effectiveness (Phase 2)Looking for participantsNCT05010681
What this trial is testing

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Testing effectiveness (Phase 2)Ended earlyNCT02994251
What this trial is testing

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Yale University 1
Load More Results